Adverse drug reactions (ADRs) are a common problem in children. Health-related quality of life in patients with such conditions has not been well studied. In this study we found that health-related quality of life is adversely affected in children who developed ADRs with cutaneous manifestations.
| OBJECTIVE
The objective of the present study was to assess the HRQL of children with ADRs with dermatologic manifestations and to evaluate how some associated conditions such as previous drug reactions, comorbidities, family income, and other factors may influence it.
| ME TH ODS
We included 112 patients consecutively referred to our ADR clinic with a probable diagnosis of ADR with cutaneous manifestations.
Parents were asked to fill out a questionnaire and HRQL was assessed using a specific (not validated) ADR-HRQL instrument partly based on the Children's Dermatology Life Quality Index (Appendix S1). After patients were assessed and diagnosed, they were divided into two groups. Group 1 included patients in whom cutaneous manifestations were not consistent with an ADR (eg, viral or bacterial exanthema, eczema). Group 2 included patients with any kind of cutaneous ADR (eg, side effect, immunoglobulin E allergy, delayed hypersensitivity). Variables were analyzed using Mann-Whitney U, chi-square, and Fisher tests as appropriate. To explore potential predictors of a diagnosis of ADR, we calculated odds ratios (ORs) using logistic regression analysis. Finally, in all patients we explored the potential effect of socioeconomic and clinical variables on HRQL using linear regression with HRQL score as the dependent variable.
| RESULTS
We included 112 patients (n=51 female, n=61 male), of whom 53 anticonvulsants (4.5%), and nonsteroidal anti-inflammatory drugs (11.9%). HRQL scores for group 1 were lower than for group 2 (Table 1) . In group 2, in 59.3% of patients with an ADR, the ADR had a moderate to extremely large effect on their HRQL, whereas in group 1 the percentage was significantly lower (22.6%) (P<.001).
Other factors, including age, sex, concomitant drugs, and comorbidities were not correlated, although lower annual family income and diagnosis of a previous ADR were associated with a lower HRQL. 
